Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Limitations of Current Evaluation Techniques for the Cost-Effectiveness of Treatments for Parkinson’s Disease

11.11.2004


Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. Pharmaceutical and surgical therapies for PD are available and can alleviate the symptoms and complications. Unfortunately, despite these therapies, the disease relentlessly progresses. A new study in the journal Value in Health presents a detailed overview of the current decision-analytic models used to evaluate the cost-effectiveness of therapeutic options in Parkinson’s disease.



Lead author Uwe Siebert notes “this article gives an insight into the different methodological approaches used to estimate the cost-effectiveness of treatments for a chronic progressive disorder. Cost-effectiveness is an important issue in PD as newer therapeutic options are costly.” Corresponding author Richard Dodel stresses, “Although each of these studies has its distinct value, most currently available models do not explicitly capture the large spectrum of clinically relevant symptoms that physicians must consider in daily clinical decision making.”

This study aims to provide decision analysts and clinicians interested in formal medical decision making with an insight into the structural and methodological approaches used in PD decision modeling, including their strengths and limitations. Studying the long-term effect of treatment on clinical symptoms and health-related quality of life is important in evaluating PD interventions. However, since most clinical trials are short, mathematical models must be used to link the short-term clinical outcomes from clinical trials with evidence for the long-term progression of the disease. PD is particularly complex because of the wide spectrum of PD symptoms and treatment complications, and the lifelong progression of the disease. The authors conclude that decision-analytic modeling is a useful tool in clinical decision-making and the economic evaluation of interventions in PD. It cannot replace clinical studies but rather complements them to better inform physicians and policy makers about the potential long-term effectiveness and costs of new and promising interventions.

Sharon Agsalda | alfa
Further information:
http://www.blackwellpublishing.com/vhe

More articles from Health and Medicine:

nachricht Chances to treat childhood dementia
24.07.2017 | Julius-Maximilians-Universität Würzburg

nachricht World first: Massive thrombosis removed during early pregnancy
20.07.2017 | Universitätsspital Bern

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

Im Focus: Laser-cooled ions contribute to better understanding of friction

Physics supports biology: Researchers from PTB have developed a model system to investigate friction phenomena with atomic precision

Friction: what you want from car brakes, otherwise rather a nuisance. In any case, it is useful to know as precisely as possible how friction phenomena arise –...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

Chances to treat childhood dementia

24.07.2017 | Health and Medicine

Improved Performance thanks to Reduced Weight

24.07.2017 | Automotive Engineering

NASA looks to solar eclipse to help understand Earth's energy system

21.07.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>